Santen
Text Size
Listen
Santen USA
  • Patients
  • Healthcare Professionals
  • Careers
  • Investors
Listen

Tap on the left to use.

  • Who We Are
    Core Principle / Our Commitment
    Core Principle / Our Commitment
    Our Values
    Our Values
    Corporate Compliance
    Corporate Compliance
    Company Information
    Santen USA
    Corporate Story
    Corporate Story
  • What We Do
    Santen 2030
    Santen 2030
    Research & Development
    Global Research & Development
    Glaucoma
    Corneal Disorders
    Refractive Disorders
    US Ophthalmic Pipeline and Clinical Trials
    Investigator-Sponsored Trials
    ​​US Product
    FLAREX®
    FRESHKOTE®
    NATACYN®
    TOBRADEX® ST
    Verkazia®
    ZERVIATE®
    Partnering
    Corporate Venture​
    Business Development​
    Partner with Us
  • Our Stories
  • Sustainability
  • News
    News
    News Releases​
    News Archive
  1. Home
  2. News Releases
  3. 2019

2019 News

Stay up to date on all that’s happening at Santen USA. For our global headquarters news, visit Santen Worldwide.

News

11.06.2019 Santen Reports Consolidated Results for Q2 Fiscal Year 2019
08.30.2019 Santen Announces Topline Pivotal Data for DE-128 (MicroShunt) Demonstrating Reductions in Intraocular Pressure and Medication Use in Patients with Mild, Moderate and Severe Primary Open-Angle Glaucoma
08.01.2019 Santen Reports the 1st Quarter Fiscal 2019 Consolidated Performance
07.03.2019 Santen Included in All Four ESG Investment Indices Selected by GPIF
06.01.2019 Santen Chooses SAP S/4HANA® Cloud and Other SAP Solutions
05.09.2019 Santen Reports Consolidated Results for Fiscal 2018
04.26.2019 Santen and Glaukos Enter into Collaboration and Distribution Agreement for Exclusive Distribution of the MicroShunt (DE-128) in the United States
03.08.2019 Santen to Conduct Activities to Raise Disease Awareness during World Glaucoma Week, March 10 to 16
02.05.2019 Santen Consolidated Financial Results for Q3 FY2018
01.30.2019 Santen Hosts Event to Raise Public Awareness of Importance of Continued Glaucoma Treatment Prior to Sponsoring World Glaucoma Week in March
01.08.2019 Santen Updates Pipeline in Corporate Presentation of January 8, 2019
News Archive

  • Sitemap
  • Terms of Use
  • Privacy Policy
  • Patient Copay Program
  • Contact
Copyright © 2023 Santen Pharmaceutical Co., Ltd.
All Rights Reserved